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Ltk- cells were transfected with total genomic DNA obtained from rat islets or from insulinoma cells mixed 
with DNA tagged with fluorescent dye. Flyorescence-activated cell sorter (FACS) was used for initial selec- 
tion of successful transfectants, monitoring fluorescent DNA incorporated into the cell. For subsequent se- 
lections the cells were treated with anti-insulin antiserum labeled with fluorescent dye and selected by FACS. 
B cell DNA, but not DNA from murine leukemic cells, induced the appearance of cell surface insulin antige- 
nicity in fibroblasts. This phenotypic expression was transient. Together with our previous demonstration 
of the induction of insulin secreation in Ltk- cells [( 1986) Biochem. Biophys. Res. Commun. 136, 638-6441, 
these results indicate that B cell specific characteristics can be transfected to non-endocrine cells by genomic 
DNA transfection. 
Fluorescent marker Cell surface Insulin 
1. INTRODUCTION 
Employing serum from insulin-dependent 
diabetic patients, it is possible to show that pan- 
creatic P-cells express cell-specific surface antigens 
[I]. In addition, recent studies demonstrated that 
the P-cell plasma membrane contains insulin-like 
antigenicity [2]. Thus, both antigens may be im- 
plicated in the autoimmune pathogenesis of type 1 
diabetes mellitus [3]. The induction of surface in- 
sulin or other @cell-specific antigens in 
heterologous non-endocrine cells could be useful 
for stimulating autoimmune reactions that mimic 
the mechanism of autoimmune insulitis. It could 
also develop into a powerful experimental tool for 
the identification of the putative enhancer se- 
quence binding factor, which is specific for the ac- 
tivation of the insulin gene enhancer sequence [4]. 
This study was undertaken to test the feasibility of 
inducing surface insulin expression in non- 
endocrine cells by transfection with DNA from 
insulin-producing cells, 
Transient expression (L-cell) genomic DNA 
In previous studies from this laboratory, tran- 
sient secretion of insulin was induced in Ltk- cells 
transfected with total genomic rat islet DNA [5], 
using thymidine kinase gene for selection. 
However, this technique is inappropriate if a large 
number of successful transfectants are desired, due 
to the excessive selection of the HAT medium and 
the interference of dying cells in the FACS. 
Therefore, to sort the entire transfected population 
for successful introduction of extraneous DNA, a 
new method using a trace of fluorescent DNA 
marker was used. 
2. MATERIALS AND METHODS 
2.1. Cells and cultures 
Thymidine kinase-deficient Ltk- fibroblasts and 
the rat insulinoma line RINmSF were maintained 
in culture in Dulbecco’s modified Eagle’s medium 
(DMEM) supplemented with 10% fetal calf serum 
(FCS, Biolab, Jerusalem). Islets of Langerhans 
from the pancreas of male albino Sabra rats were 
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isolated by collagenase digestion [6]. Murine 
leukemic tumor cells (YAC) were grown in an 
ascitic form in the peritoneal cavity of A/sn mice 
[71. 
2.2. Immunological reagents 
Guinea-pig anti-pork insulin was purchased 
from Linco Research Inc. (Eureca, MO), fluores- 
cein isothiocyanate (FITC) conjugate of rabbit 
anti-guinea-pig IgG and FITC conjugate of rabbit 
anti-mouse IgG were from Sigma (St. Louis, MO). 
Anti-leukemic antibodies, shown to bind 50-80% 
of YAC cells on fluorescence-activated cell sorter 
(FACS) analysis were kindly provided by Dr R. 
Sharon, Hebrew University School of Medicine, 
Jerusalem. All sera were treated at 56°C for 
30 min for complement inactivation, absorbed on 
non-transfected Ltk- cells at 4°C for 30 min and 
then spun for 5 min in an Eppendorf minicen- 
trifuge (FRG). 
2.3. DNA extraction 
Cells or islets were suspended in 10 mM Tris, pH 
7.5, containing 10 mM EDTA and incubated for 
2 h in 2% SDS and lOOpg/ml proteinase (Sigma) 
at 37°C under gentle swirling. Two rounds of 
phenol extractions and 2 rounds of chloroform ex- 
tractions were then applied to remove phenol 
traces, followed by dialysis against 3000 vols 
distilled water. The extract was then run on 1% 
agarose gel electrophoresis [8] to confirm the 
presence of large DNA fragments (>20 kb). For 
fluorescence-labelled DNA, 100 pg high-M, DNA 
were mixed with 50 pg ethidium bromide in 10 mM 
Tris, pH 7.5, or with FITC in 10 mM Tris, pH 9.5, 
incubated at room temperature for 30 min and 
dialyzed twice against 3000 vols distilled water. 
2.4. Transfection of Ltk- ceils 
Ltk- fibroblasts (1 x 106), seeded 24-48 h 
earlier in 100 mm petri dishes (NUNC, Roskildas, 
Denmark), were cotransfected with 0.1 ,ug 
fluorescence-labelled DNA mixed with 10 ,ug 
freshly extracted genomic DNA per dish, using the 
calcium precipitation method [9]. After 6 h the 
cells were rinsed with DMEM and further cultured 
in DMEM containing 10% FCS. On the following 
day, the cells were removed by gentle trypsiniza- 
tion, washed 3 times in cold DMEM containing 
10% FCS, and resuspended in the same medium at 
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a concentration of lo6 cells/ml for cell sorting. 
During the entire procedure, exposure to light was 
restricted to a minimum. 
2.5. Ceil sorting 
Cells were sorted under sterile conditions on an 
FACS IV-400 (Becton & Dickinson, Los Angeles, 
CA). Cells transfected with ethidium bromide were 
excited at 360 nm while the emission wavelength 
was 560 nm. For FITC selection 360 nm was used 
for excitation and 490 nm for the emission 
wavelength. Rating for high fluorescence intensity 
was set arbitrarily above the broken cells 
background. Cells demonstrating high-intensity 
fluorescence were collected in a sterile tube con- 
taining 1 ml growth medium, seeded in 50 mm 
petri dishes, and grown to a density of 2-5 x 10’ 
cells per dish. Selection for cell-surface insulin-like 
antigenicity was carried out l-6 weeks post- 
transfection. The transfectants were rinsed with 
cold Krebs-Ringer (KRB) solution containing 
0.5% BSA and incubated for 30 min at 37°C in 
KRB containing either 3.3 or 16.7 mM glucose. 
The cells were then incubated for an additional 
30 min at 4°C with guinea-pig anti-insulin serum, 
diluted 1: 100 in KRB, rinsed with KRB, and 
reacted with a 1: 200 dilution of FITC conjugate of 
anti-guinea-pig IgG for 30 min at 4°C. After the 
excess fluorescent antibodies were removed by 
washing, the cells were gently trypsinized and 
washed 3 times more in cold DMEM containing 
10% FCS and resuspended at lo6 cells/ml for 
FACS analysis. 
3. RESULTS 
DNA extracted from RINmSF insulinoma cells 
was marked with ethidium bromide and used to 
transfect Ltk- fibroblasts as described in section 2. 
For selection by the FACS, the vertical gate for 
positive fluorescent cells was set at lo/255 screen 
divisions above the upper border of the bulk of 
fluorescent cells (in accord with the auto- 
fluorescence of non-transfected Ltk- cells). The 
horizontal gate was set between 60/255 and 
255/255 screen divisions. A typical profile of 
FACS sorting is shown in fig.lA; 2% of the cells 
were collected (to the right of the arrow) and 
reseeded. 1 week later the cells were labelled with 
guinea-pig anti-insulin serum and FITC conjugate 
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Fig.1. Sorting and analysis for cell-surface insulin 
expression in fibroblasts transfected with DNA from 
RINmSF cells, using ethidium bromide as a marker for 
successful transfections. (A) Ltk- cells 24 h after 
transfection with RINmSF DNA mixed with 1% of the 
same DNA tagged with ethidium bromide; excitation 
wavelength, 360 nm; emission wavelength, 560 nm. All 
cells to the right of the arrow were collected and cultured 
for a second sorting. (B) Second sorting using guinea-pig 
anti-insulin serum and FITC-conjugated rabbit anti- 
guinea-pig IgG. Emission wavelength, 488 nm. All cells 
to the right of the arrow were collected and cultured for 
later analysis. (C) Analysis of surface insulin-expressing 
cells 2 weeks post transfection. Cells treated with: (1) 
guinea-pig anti-insulin serum (1: 100) as first antibody, 
(2) normal guinea-pig serum (1: lOO), (3) KRB buffer 
alone. 
of anti-guinea-pig IgG. A wide range of 
fluorescence intensities was observed among the 
positive fluorescent cells of the 2nd FACS analysis 
(to the right of the arrow in fig. 1B). High-intensity 
fluorescing cells were collected and further grown 
for 2 weeks, at which time the sorting with anti- 
insulin antibodies was repeated. A homogeneous 
population of highly fluorescent cells was obtained 
in the 3rd FACS analysis (peak in fig.lC) cor- 
responding to the fraction of cells retaining tran- 
sient insulin antigenicity for long periods. 
FITC has not been reported to bind significantly 
double-stranded DNA. We compared FITC with 
ethidium bromide as a fluorescent marker for 
DNA transfection because of its low toxicity [lo]. 
Ltk- cells transfected with FITC, or ethidium 
bromide-treated DNA mixed with native rat islet 
DNA, underwent initial sorting on the FACS. The 
positive fluorescent cells were propagated for l-3 
weeks and then either analyzed and discarded or 
sorted for further propagation. To obtain a curve 
Fig.2. Loss of phenotypic expression of surface 
antigenicity in transfected fibroblasts. The initial point 
of total (100%) transfected cells was determined on day 
1 post-transfection with either ethidium bromide-treated 
DNA (a,b) or FITC-treated DNA (c,d). Subsequent 
points on each curve represent analysis of the phenotype 
by its respective antiserum and an FITC-conjugated 
second antibody. (A) Ltk- cells transfected with rat islet 
DNA mixed with ethidium bromide-tagged rat islet 
DNA. (B) Ltk- cells transfected with YAC murine 
leukemic DNA mixed with the same DNA tagged with 
ethidium bromide. The phenotype was determined by an 
anti-YAC serum from syngeneic mice. [The anti- 
leukemic serum was a pool of sera from 10 mice injected 
with a 170 kDa section of leukemic cell homogenate. 
These mice became resistant to increasing challenges of 
live tumor. Their serum pool bound up to 80% of these 
leukemic cells and stained a 105 kDa protein (not 
shown).] (C) LTK- cells transfected with YAC murine 
leukemic DNA mixed with the same DNA tagged with 
FITC. The phenotype was determined with anti-YAC 
serum. (D) Ltk- cells transfected with rat islet DNA 
mixed with the same DNA tagged with FITC. Surface 
phenotype expression was determined using anti-insulin 
serum. 
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for the rate by which the surface insulin expression 
was lost, the fractional yield of high fluorescence 
cells was multiplied by that figure of the previous 
sorting (fig.2). The curves that describe the 
phenotypic loss in transient transfectants initially 
selected by FITC-treated DNA had a steeper slope 
than the ethidium bromide-selected transfectants. 
This suggests that selection by FITC DNA is less 
efficient in defining the total transfected popula- 
tion on day 1 by one order of magnitude as com- 
pared with the ethidium bromide-labeled DNA 
method (see differences between curves a and b vs 
c and d in fig.2). However, since ethidium bromide 
is highly mutagenic, FITC was preferred for cell 
sorting. Fig.3 presents FACS analysis of cells in- 
FLUORESCENCE INTENS. 
Fig.3. Inhibition of surface insulin antibody binding by 
insulin. Transfectants were sorted on day 1 by the 
fluorescence of FITC-treated DNA mixed with native 
rate islet DNA. (C) First isolation of total transfectants; 
(C2) third FACS run with anti-insulin antibodies; 
(C2 + insulin) cell sorted according to anti-insulin 
binding after excess insulin (10 mu/ml) was added to 
Fig.4. DNA specificity of surface insulin expression in 
transfected fibroblasts. (A) Ltk- cells transfected with 
FITC-treated DNA mixed with (1) islet ‘DNA, (2) 
leukemic cell DNA, (3) autofluorescence of non- 
transfected Ltk- cells. (B) 3 weeks post-transfection of 
fibroblasts with rat islet DNA. (1) Islet DNA 
transfectants incubated with anti-insulin antibodies, (2) 
islet DNA transfectants incubated with anti-leukemic 
serum, (3) leukemic DNA transfectants incubated with 
anti-insulin serum. [20% of leukemic DNA transfectants 
bound the anti-leukemic serum above the background of 
the incubation medium. rat islet DNA transfectants (not shown).] 
itially sorted on the basis of incorporation of FITC- 
treated islet DNA. Curve C in fig.3 represents them 
first sorting of cells, monitoring binding of 
fluorescently labelled anti-insulin antibodies. 
Curve C2 is the third such sorting. The anti-insulin 
antibody binding to the cells was inhibited by rat 
insulin added at the incubation step, confirming 
the specificity of this antigen-antibody reaction 
(C2 + insulin). 
The specific requirement for DNA of B cell 
origin [ 1 l] was examined in our system using DNA 
extracted from mouse leukemia cells and anti- 
leukemic serum. Fibroblasts were transfected 
either with islet DNA (curve 1) (fig.4A) or 
leukemia DNA (curve 2) and sorted initially on the 
basis of trace FITC-labeled DNA fluorescence. 3 
weeks later, only fibroblasts transfected with islet 
DNA bound anti-insulin antibodies (curve 1 in 
fig.4B); transfection with leukemia DNA did not 
induce expression of insulin (curve 3, fig.rlB), nor 
A B 
FLUORESCENCE INTENS. 
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did islet DNA-transfected cells react with anti- 
leukemic serum (curve 2, fig.4B); in contrast, 
fibroblasts transfected with leukemic cell DNA 
strongly bound anti-leukemic antibodies (not 
shown). 
4. DISCUSSION 
Regulated insulin secretion, namely the glucose- 
sensitive gene(s) transcription, processing and 
translation of product(s) RNA, processing of the 
product preproinsulin and controlled secretion of 
the final product, is believed to be an exclusive 
characteristic of pancreatic B cells. Attempts to 
obtain secretion of intact insulin from non- 
endocrine cells, regulated or unregulated, were 
mostly unsuccessful. Thus transfection of Ltk- 
cells with cloned insulin gene produced no product 
transcription [ 121 or low-grade transcription [ 131. 
On the other hand, insulin secretion was reported 
in an ACTH-secreting cell line transfected with 
cloned insulin gene [ 131. Thus, it seems that 
transfection of the insulin gene into cells sharing 
common embryonic origin with B cells, i.e. neural 
crest APUD cells, may lead to transcription of the 
complete hormone, a finding compatible with the 
concept of tissue-specific gene expression. 
Recent studies have demonstrated that the im- 
munoglobulin gene enhancer sequence may be in- 
troduced in a stable form into Ltk- cell and 
activated by specific protein factors [ 16,171. Using 
total genomic DNA from B cells for transcription, 
we have succeeded in obtaining transient expres- 
sion of regulated insulin secretion in L cells [5]. In 
these studies, we have used large DNA fragments 
(20-100 kb) for transfection. Since the DNA was 
obtained from insulin-producing cells, it is con- 
ceivable that in addition to the preproinsulin gene, 
genomic regions responsible for the expression of 
the factors activating the enhancer sequencer [4] 
have been cotransfected with regions responsible 
for hormonal processing and release. 
Transfection with large fragments of B cell total 
genomic DNA was also used in this study to 
demonstrate transient surface insulin-like antigenic 
expression. Cell-surface insulin-like antigenicity 
has been previously reported in pancreatic B cells 
121, and this study demonstrates that such an ex- 
pression can only be obtained if the DNA used was 
of B cell origin (fig.4). This finding is compatible 
with the cell-specific gene expression concept. 
The incorporation of extraneous DNA into host 
L cells was followed in this study by monitoring 
the fluorescence of ethidium bromide-tagged DNA 
or of FITC-tagged DNA. In combination with 
FITC-labelled anti-insulin antibody binding, this 
method was also used to obtain an estimate of the 
rate of disappearance of the phenotypic expression 
of the donor DNA as described by Scangos et al. 
[18]. Although cell sorting by the ethidium 
bromide method was more efficient than by the 
FITC-labelled DNA procedure (fig.2), due to the 
relative mutagenicity of ethidium bromide as com- 
pared to FITC, the latter was preferred. Attempts 
to use anti-insulin antibodies for the entire period 
of sorting were not successful. 
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